|
시장보고서
상품코드
2051296
3D 바이오프린팅 시장 : 기술별, 구성부품별, 용도별, 지역별3D Bioprinting Market, By Technology, By Component, By Application, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
3D 바이오프린팅 시장은 2026년에 34억 4,000만 달러로 추정되며, 2033년까지 100억 8,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 16.6%를 기록할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 34억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 16.60% | 2033년 시장 규모 예측 : | 1,080억 달러 |
3D 바이오프린팅은 의료 연구 및 임상 적용을 목적으로 3D 프린터를 사용하여 인체 조직, 장기, 생화학 물질을 인쇄하는 새로운 혁신 기술입니다. 이 기술은 생체 조직 형성을 지원할 수 있는 살아있는 세포, 스캐폴더, 성장인자를 층층이 쌓아 올리는 방식으로 작동합니다. 이 선구적인 접근 방식은 이식 가능한 장기 부족 문제를 해결함으로써 의료계에 혁명을 일으킬 수 있는 큰 잠재력을 가지고 있습니다. 컴퓨터 지원 설계를 기반으로 생체 재료, 살아있는 세포 및 지지 인자를 공간적으로 정밀하게 증착하여 복잡한 3D 조직 및 장기 구조를 제작할 수 있습니다. 3D 바이오프린팅은 조직과 장기의 원래 미세 환경을 재현함으로써 재생의료 분야를 가속화하고, 궁극적으로 장기 이식 수요를 충족시킬 수 있습니다.
시장 역학
세계 3D 바이오프린팅 시장은 재생의료 연구에 대한 자금 지원과 노력 증가에 힘입어 성장하고 있습니다. 장기 이식에 대한 수요 증가와 기증자 부족으로 인해 바이오프린팅 기술이 제공하는 대체 솔루션에 대한 투자가 확대되고 있습니다. 유리한 규제 가이드라인과 바이오프린트 조직의 상업화가 수익성 높은 기회를 창출하고 있습니다. 그러나 높은 운영 비용과 복잡한 생체 구조물을 프린팅할 때 발생하는 기술적 문제들이 제약이 되고 있습니다. 숙련된 전문 지식의 부족과 임상시험의 미정비도 보급에 걸림돌이 되고 있습니다. 그럼에도 불구하고 각 업체들은 생체 재료, 세포와의 적합성, 3D 바이오 프린터의 해상도를 향상시키기 위해 협력하고 있습니다. 약동학 시험, 맞춤형 약물 스크리닝, 희귀질환 모델링과 같은 새로운 응용 분야의 출현은 예측 기간 동안 시장 성장을 가속할 수 있습니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 3D 바이오프린팅 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 3D 바이오프린팅 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 3D 바이오프린팅 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 3D 바이오프린팅 시장 : 기술별, 2021년-2033년
제5장 세계의 3D 바이오프린팅 시장 : 컴포넌트별, 2021년-2033년
제6장 세계의 3D 바이오프린팅 시장 : 용도별, 2021년-2033년
제7장 세계의 3D 바이오프린팅 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 기회 분석
제10장 섹션
LSH 26.06.183D Bioprinting Market is estimated to be valued at USD 3.44 Bn in 2026 and is expected to reach USD 10.08 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.44 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 16.60% | 2033 Value Projection: | USD 10.08 Bn |
3D bioprinting is an emerging and innovative technology that utilizes 3D printers to print human tissues, organs, and biochemicals for medical research and clinical applications. It works by layering live cells, scaffolds, and growth factors capable of supporting the formation of biological tissues. This pioneering approach holds enormous potential in revolutionizing healthcare by addressing the shortage of transplantable organs. It allows the fabrication of complex 3D tissues and organ structures through precise spatial deposition of biomaterials, living cells, and supporting factors based on computer-assisted design. By replicating the native microenvironment of tissues and organs, 3D bioprinting can accelerate the field of regenerative medicine and ultimately address the demand for organ transplants.
Market Dynamics
The global 3D bioprinting market is driven by rising funding and initiatives for research in regenerative medicines. The growing demand for organ transplants and lack of donors has boosted investments in alternative solutions offered by bioprinting technologies. Favorable regulatory guidelines and commercialization of bioprinted tissues are creating lucrative opportunities. However, high operational costs and technical challenges in printing complex living structures pose constraints. Lack of skilled expertise and clinical trials also challenge widespread adoption. Nonetheless, companies are collaborating to improve biomaterials, cell compatibility, and resolution of 3D bioprinters. The emergence of newer application areas such as pharmacokinetic testing, personalized drug screening, and rare disease modeling can boost the market growth during the forecast period.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global 3D bioprinting market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include 3D Bioprinting Solutions, Advanced Solutions Life Sciences, LLC, Allevi Inc., Aspect Biosystems Ltd., Bico group ab, Bio3D Technologies Pte. Ltd., Cellink Global, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Electro Optical Systems, Envisiontec GmbH, Foldink Life Science Technologies, Formlabs, Inc., GE Healthcare, Inventia Life Science PTY LTD, Nano 3D Biosciences, Inc., Optomec Inc., Organovo Holdings, Inc., Pandorum Technologies pvt. ltd., Precise Bio, Regemat 3D S.L., Regenovo Biotechnology Co. Ltd., Renishaw plc., Revotek co., ltd., Rokit Healthcare, inc., Stratasys Ltd.Vivax Bio, LLC, and Vivax Bio, LLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global 3D bioprinting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D bioprinting market
Market Segmentation
- By Technology (Revenue, USD Bn, 2021 - 2033)
- Syringe/extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
- Others
- By Component (Revenue, USD Bn, 2021 - 2033)
- 3D Bioprinters
- Biomaterials
- Scaffolds
- By Application (Revenue, USD Bn, 2021 - 2033)
- Drug Testing and Development
- Regenerative Medicine
- Food Testing
- Research
- Others
- By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Rest of Middle East & Africa
- Key Players Insights
- 3D Bioprinting Solutions
- Advanced Solutions Life Sciences, LLC
- Allevi Inc.
- Aspect Biosystems Ltd.
- Bico group ab
- Bio3D Technologies Pte. Ltd.
- Cellink Global
- Collplant Biotechnologies Ltd.
- Cyfuse Biomedical K.K.
- Electro Optical Systems
- Envisiontec GmbH
- Foldink Life Science Technologies
- Formlabs, Inc.
- GE Healthcare
- Inventia Life Science PTY LTD
- Nano 3D Biosciences, Inc.
- Optomec Inc.
- Organovo Holdings, Inc.
- Pandorum Technologies pvt. ltd.
- Precise Bio
- Regemat 3D S.L.
- Regenovo Biotechnology Co. Ltd.
- Renishaw plc.
- Revotek co., ltd.
- Rokit Healthcare, inc.
- Stratasys Ltd.Vivax Bio, LLC
- Vivax Bio, LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Component
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global 3D Bioprinting Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Syringe/ extrusion bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Inkjet Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Magnetic Levitation Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Laser Assisted Bioprintings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global 3D Bioprinting Market, By Component, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- 3D Bioprinters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Scaffolds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global 3D Bioprinting Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Drug Testing and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Food Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global 3D Bioprinting Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Country Trends
- North America
- Regional Trends
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country, 2026 and 2033 (%)
- U.S.
- Canada
- Europe
- Regional Trends
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country, 2026 and 2033 (%)
- U.K.
- Germany
- France
- Russia
- Rest of Europe
- Asia Pacific
- Regional Trends
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country, 2026 and 2033 (%)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Regional Trends
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast, By Technology, 2021-2033 (USD Billion)
- Market Size and Forecast, By Components, 2021-2033 (USD Billion)
- Market Size and Forecast, By Application, 2021-2033 (USD Billion)
- Market Share Analysis, By Country/region, 2026 and 2033 (%)
- South Africa
- GCC Countries
- Rest of the Middle East & Africa
8. Competitive Landscape
- Company Profiles
- 3D Bioprinting Solutions
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Advanced Solutions Life Sciences, LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Allevi Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Aspect Biosystems Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Bico group ab
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Bio3D Technologies Pte. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Cellink Global
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Collplant Biotechnologies Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Cyfuse Biomedical K.K.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Electro Optical Systems
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Envisiontec GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Foldink Life Science Technologies
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Formlabs, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Inventia Life Science PTY LTD
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Nano 3D Biosciences, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Optomec Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Organovo Holdings, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Pandorum Technologies pvt. ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Precise Bio
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Regemat 3D S.L.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Regenovo Biotechnology Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Renishaw PLC.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Revotek Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Rokit Healthcare, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Stratasys Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Vivax Bio, LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- 3D Bioprinting Solutions
9. Wheel of Fortune
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. Section:
- Research Methodology
- About Us
